300347 泰格医药
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)9.97210.64316.78717.20224.416
总资产报酬率 ROA (%)7.0897.84013.29212.94314.250
投入资产回报率 ROIC (%)8.2779.11015.26415.41619.057

边际利润分析
销售毛利率 (%)38.57739.63743.55347.43546.477
营业利润率 (%)33.68036.44670.91169.61538.692
息税前利润/营业总收入 (%)32.23534.25766.52372.26139.194
净利润/营业总收入 (%)29.11632.06265.05663.56034.792

收益指标分析
经营活动净收益/利润总额(%)73.53474.60942.76734.76966.802
价值变动净收益/利润总额(%)27.76524.70157.74664.07633.496
营业外收支净额/利润总额(%)0.0640.115-0.337-0.1620.415

偿债能力分析
流动比率 (X)2.7412.9784.49810.2221.882
速动比率 (X)2.7352.9724.49510.2181.881
资产负债率 (%)17.61117.36313.2090.08426.697
带息债务/全部投入资本 (%)14.35313.7117.7993.43019.586
股东权益/带息债务 (%)578.707604.9151,136.8152,729.354393.459
股东权益/负债合计 (%)402.258410.935577.926978.316210.117
利息保障倍数 (X)-21.973-15.350-16.03026.198114.954

营运能力分析
应收账款周转天数 (天)55.78646.66544.88588.281119.152
存货周转天数 (天)1.8101.1910.6620.6360.207